Ina Perkins
Directeur Général chez Scandinavian Real Heart AB
Profil
Ina Laura Perkins is currently the Chief Executive Officer at Scandinavian Real Heart AB.
Previously, she worked as the Head of Research at Calon Cardio-Technology Ltd.
She holds an MBA from Stockholm School of Economics and a doctorate from Swansea University.
Postes actifs de Ina Perkins
| Sociétés | Poste | Début |
|---|---|---|
Scandinavian Real Heart AB
 Scandinavian Real Heart AB Medical SpecialtiesHealth Technology Scandinavian Real Heart AB engages in the development of mechanical cardiac pumps. It offers an artificial heart that recreates the flow, pressure, and control of a pumping heart and can be used for patients awaiting heart transplants. The company was founded by Azad Najar, Gunnar Nihlén, and Said Zahrai in 1999 and is headquartered in Västerås, Sweden. | Directeur Général | - |
Anciens postes connus de Ina Perkins
| Sociétés | Poste | Fin |
|---|---|---|
Calon Cardio-Technology Ltd.
 Calon Cardio-Technology Ltd. Medical SpecialtiesHealth Technology Calon Cardio-Technology Ltd. develops implantable micro blood pumps for the treatment of chronic heart failure. Its lead product, the MiniVAD, a miniature implantable blood pump, is being developed for implantation directly into the left ventricle of the failing heart to help provide adequate blood supply to the body, alleviate the debilitating symptoms of heart failure and improve quality of life. The company was founded by Marc Clement in 2007 and is headquartered in Swansea, the United Kingdom. | Directeur Technique/Scientifique/R&D | - |
Formation de Ina Perkins
| Stockholm School of Economics | Masters Business Admin |
| Swansea University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
 | Health Technology |
| Entreprise privées | 1 |
|---|---|
Calon Cardio-Technology Ltd.
Calon Cardio-Technology Ltd. Medical SpecialtiesHealth Technology Calon Cardio-Technology Ltd. develops implantable micro blood pumps for the treatment of chronic heart failure. Its lead product, the MiniVAD, a miniature implantable blood pump, is being developed for implantation directly into the left ventricle of the failing heart to help provide adequate blood supply to the body, alleviate the debilitating symptoms of heart failure and improve quality of life. The company was founded by Marc Clement in 2007 and is headquartered in Swansea, the United Kingdom. | Health Technology |
